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656Objective: Thymectomy is often performed to secure an operative field in surgery for congenital heart defects in
early infancy. However, how neonatal thymectomy affects the subsequent development of the immune system in
humans remains unclear. We monitored patients for 3 years from the time of thymectomy that was performed
during cardiac surgery in early infancy.
Methods: For up to 3 years, we monitored the number of circulating lymphocytes and the clinical course of the
children who underwent complete (n¼ 17), partial, and no (n¼ 15) thymectomy during congenital heart defect
surgery performed at less than 3 months of age. The titers of immunoglobulin-G produced in response to vac-
cinated viruses and phytohemagglutinin responses were also measured.
Results: Six months after surgery, the number of T cells, including CD4þ and CD8þ subpopulations, decreased
in patients with complete but not partial thymectomy. The reduction in T-cell number persisted for 3 years,
whereas the number of B cells did not change. In patients with complete thymectomy, the titers of
immunoglobulin-G produced in response to vaccinated measles and rubella viruses were reduced, whereas
the phytohemagglutinin-induced proliferation of T cells was not impaired. In addition, hospitalization frequency
associated with infectious diseases increased in patients with complete but not partial thymectomy.
Conclusions: The results revealed that complete thymectomy in early infancy reduces the number of circulating
T cells and T-cell–mediated immune responses for at least 3 years, suggesting that the thymus should be at least
partially preserved during surgery in early infancy to maintain protective immunity. (J Thorac Cardiovasc Surg
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The Journal of Thoracic and Cardiovascular SurgThe thymus is essential for supporting the differentiation and
repertoire selection of T lymphocytes during embryogenesis.
In humans and mice, genetic mutations in the transcription
factor Foxn1 result in the nude phenotype, which is associated
with defective development of thymic epithelial cells and con-
genital loss of the thymus, resulting in marked reduction in
T-cell number and severe combined immunodeficiency.1,2
Patients with chromosome 22q11.2 deletion syndrome,
which is frequently associated with congenital defects
caused by mutations in the transcription factor Tbx1,
occasionally manifest loss of the thymus accompanied by
severe reduction in T-cell number and recurrent infections.3,4
However, how the surgical resection of the thymus during
early infancy affects subsequent immune system
development in humans has not been fully elucidated.5-9
Neonatal thymectomy is often performed to secure an op-
erative field in surgery for congenital heart defects (CHDs)
in early infancy.5 In particular, complete thymectomy is
commonly practiced during surgery for severe CHDs,
such as an arterial switch for the transposition of great ar-
teries and the Norwood operation for hypoplastic left heart
syndrome.5 Many studies have established that neonatal
thymectomy reduces the subsequent number of circulatingery c March 2013
Abbreviations and Acronyms
CHD ¼ congenital heart defect
CPB ¼ cardiopulmonary bypass
Ig ¼ immunoglobulin
PHA ¼ phytohemagglutinin
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DT cells.6,10,11 However, the clinical effects of neonatal
thymectomy remain unclear.11 Some studies have shown
that the immune function is not compromised and the fre-
quency of infectious events is not increased.7,8 On the
other hand, a recent study has shown a diminished
response to tick-borne encephalitis vaccination in thymec-
tomized children,9 although the wide distributions of the
age at the time of thymectomy and the duration of monitor-
ing post-thymectomy have hampered the in-depth evalua-
tion of short- and long-term effects. Indeed, it is well
appreciated that the timing of neonatal thymectomy affects
the development of the immune system in mice in different
ways. Severe immunodeficiency is caused by thymectomy
immediately after birth,12,13 whereas thymectomy at 2 to
4 days after birth causes autoimmune diseases associated
with a decrease in regulatory T-cell number in mice.14,15
The current study aims to clarify how complete and par-
tial thymectomy in patients with CHD who are aged less
than 3 months at the time of surgery affects the subsequent
cellularity of circulating lymphocytes, T-cell–mediated
immune responses, and clinical course.MATERIALS AND METHODS
Patients
The study was performed in cooperation with Tokushima University
Hospital, Kagawa National Children’s Hospital, and Ehime Prefectural
Central Hospital, and was conducted under the authorization of and review
by the institutional boards of the 3 hospitals (approved title: ‘‘Assessment
of Immune System in Childhood After Thymus Extirpation at Cardiac Op-
eration,’’ approval number ‘‘176’’). The study was registered with the Uni-
versity Hospital Medical Information Network (ID: UMIN000002255).
Written informed consent for this study was obtained from all the parents
of the patients. Infants aged less than 3 months who underwent surgery for
CHDs were enrolled after receipt of the parents’ written informed consent.
Patients with trisomy 21 and chromosome 22q11.2 deletion syndromewere
excluded. Thirty-two patients were enrolled during the period from 2005 to
2009. Seventeen patients underwent complete thymectomy during surgery
for CHDs to secure a safe operative field for the ascending aorta for arch
repair, such as arterial switch, truncus repair, Norwood operation, and in-
terruption/coarctation repair (Table E1). Nine patients underwent partial
extirpation of less than 60% of the thymus, and 6 patients underwent sur-
gery without thymectomy. Complete thymectomywas not needed for these
patients (Table E2). None of these patients received preoperatively steroids
or catecholamines, including epinephrine. All the patients in this study
received transfusion perioperatively.
Patient Grouping
As far as we examined, all the parameters examined in this study
showed no significant differences between the patients who underwent par-
tial thymectomy and patients who did not undergo any thymectomy. ForThe Journal of Thoracic and Caexample, the numbers of CD3þCD19 T cells and CD3CD19þ B cells
in 3 patients who underwent partial thymectomy and in 3 patients who
did not were not significantly different (Figure E1). We therefore divided
our patients into 2 groups: group C with complete thymectomy (17 pa-
tients) and group P with partial thymectomy or without thymectomy (15
patients). Patients aged less than 20 days at the time of surgery, and there-
fore showing no significant difference in age, were further subdivided into
subgroups C’ and P’ to identify the effects of thymectomy on the immune
system.We compared between these age-matched patients in group C’ who
underwent complete thymectomy (14 patients) and group P’ with partial
thymectomy or without thymectomy (6 patients) (Figure E2). Where indi-
cated, group P or P’ patients with and without cardiopulmonary bypass
(CPB) at the time of surgery were identified. CPB was carried out in all
group C patients.
Follow-up and Blood Cell Examination
The parents of these patientswere interviewed at least every 6months, es-
pecially with regard to the incidence of infectious events. The number of
white blood cells in peripheral blood wasmeasured every 6months after sur-
gery. CD3þCD19 T cells, CD4þCD8 helper T cells, CD4CD8þ
cytotoxic T cells, andCD3CD19þBcellswere analyzed byflowcytometry.
CD4þCD25þFoxp3þ regulatory T cells weremeasured 3 years after surgery.
Vaccination
All patients were administered preventive vaccination against measles
and rubella viruses. The first vaccination was performed by subcutaneous
injection between 1 and 2 years of age. Immunoglobulin (Ig)G antibody titer
was measured by SRL Inc (Tokyo, Japan). An IgG antibody titer that ex-
ceeded 4 units was clinically determined to be positive for the antibody.
Measurements of T-Cell–Mediated Immune
Responses
Titers of the IgG antibody to the vaccinated viruses were measured at 3
years of age by enzyme immunoassay. Phytohemagglutinin (PHA)-in-
duced proliferation of T cells in 3-day cultures was measured by 3H-TdR
incorporation in the last 8 hours of culture.
Statistical Analysis
Means and standard deviations were analyzed using Statistics 18.0
software (IBM SPSS Inc, Chicago, Ill). Significance of difference was
determined by the nonpaired Student t test assuming normal distribution.RESULTS
Patients’ Characteristics and Surgical Procedures
The age at the time of surgery was 14.9  16.4 (range,
3-72) days for group C, which was significantly less than
33.2  21.4 (range, 5-90) days for group P (Figure E2).
Group C patients tended to have severe CHDs, including
hypoplastic left heart syndrome and transposition of the
great arteries, which necessitated earlier surgery than group
P patients who had CHDs, including patent ductus arterio-
sus and ventricular septal defect (Tables E1 and E2). The
severity of CHDs affected not only the age at the time of
surgery but also the complexity of the surgical procedure,
thereby influencing the decision of whether the thymus
should be completely removed or partially preserved.
Nonetheless, the mean body weights at surgery were
3.2  0.4 (range, 2.5-4.4) kg in group C and 3.4  0.7
(range, 2.5-4.5) kg in group P, which were notrdiovascular Surgery c Volume 145, Number 3 657
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Dsignificantly different, suggesting that overall patient
development was not significantly different between the 2
groups. However, to normalize the age, the severity of
CHDs, and surgical procedures in the comparison
between groups C and P, we also compared the data from
patients aged less than 20 days at the time of surgery,
with no significant difference in age (Figure E2). Where in-
dicated, group P patients with and without CPB during sur-
gery were identified.
Tracing the Number of Peripheral Blood Cells After
Surgery
The numbers of white blood cells, total lymphocytes,
CD3þCD19 T cells, CD4þCD8 helper T cells,
CD4CD8þ cytotoxic T cells, and CD3CD19þ B cells be-
fore surgery were not significantly different between groups
C and P (Figure 1, A) and between groups C’ and P’
(Figure 1, B), indicating that immune system development,
including T- and B-cell development, before surgery was
not significantly different between these groups. However,
at 6 months after surgery, the numbers of total lymphocytes,
CD3þCD19 cells, CD4þCD8 cells, and CD4CD8þ
cells decreased significantly in group C compared with
those in group P (Figure 1, A). The reduction in the number
of these cells in group C persisted for at least 3 years after
surgery (Figure 1, A). The reduction in the number of T cells
also was detected in group C’ in the age-matched compari-
son between groups C’ and P’ (Figure 1, B). The number of
CD4þCD25þFoxp3þ regulatory T cells, which were mea-
sured 3 years after surgery, also decreased significantly in
group C compared with group P (Figure 1, C) and in group
C’ compared with group P’ (Figure 1, D). There was no dif-
ference in the number of regulatory T cells in group P or P’
patients with and without CPB during surgery (Figure 1, C
and D). On the other hand, the number of CD3CD19þ
B cells did not decrease in group C or group C’ (Figure 1,
A and B). These observations indicate that complete but
not partial thymectomy results in specific reduction in the
number of circulating T cells, including regulatory T cells,
for at least 3 years after surgery.
Vaccination-Induced Immunoglobulin-G Responses
and Phytohemagglutinin Responses
All patients were vaccinated against rubella and measles
viruses between 1 and 2 years of age. At 3 years after sur-
gery, the IgG antibody titers to measles and rubella viruses
were significantly lower in group C patients than in group P
patients (Figure 2, A) and in group C’ patients than in group
P’ patients (Figure 1, B). On the other hand, T cells isolated
from groups C and P (and groups C’ and P’) showed com-
parable responses to PHA stimulation (Figure 2, C and D).
The PHA responses of T cells seemed comparable between
group P or P’ patients with and without CPB (Figure 2, C
and D). Thus, completely but not partially thymectomized658 The Journal of Thoracic and Cardiovascular Surgpatients exhibit poor T-cell–mediated IgG responses to vac-
cinated viruses in vivo, although their T cells are normally
capable of mitogen responses per cell basis in vitro.
Clinical Course
No deaths were recorded during the 3-year survey period.
None of the patients required intensive care because of im-
munologic complications, including acute or recurrent
infectious diseases, such as bacteremia and mediastinitis.
The frequency of outpatient consultation was not signifi-
cantly different between the groups (Figure 3, A and B).
However, the frequency of hospitalization, which was asso-
ciated with infectious diseases such as bronchitis and pneu-
monia, was significantly higher in group C patients than in
group P patients (Figure 3, A) and in group C’ patients than
in group P’ patients (Figure 3, B). There were no differences
in hospitalization for group P or P’ patients with and with-
out CPB (Figure 3, A and B).
DISCUSSION
Our time-course analysis of age-defined and age-matched
patients has revealed a decrease in T-cell number in com-
pletely thymectomized patients. In the completely thymec-
tomized patients, titers of the IgG antibody to the
vaccinated viruses were significantly decreased, whereas
PHA responses of isolated T cells were not attenuated and
the number ofB cellswas not reduced, suggesting that the de-
fective IgG responses are due to the decrease in T-cell num-
ber. We also showed that completely thymectomized
infants experienced increased frequency of hospitalization
associated with infectious diseases. It has been unclear
whether protective immune responses are compromised in
thymectomized patients.6-8,16 A recent report9 has indicated
that 28 24-month-old (840 720-day-old) thymectomized
children exhibit both a diminished response to thefirst/second
vaccination for tick-borne encephalitis and a normal respon-
se to the third vaccination. However, our study has revealed
that complete but not partial thymectomy in 0.50  0.56-
month-old (14.9 16.8-day-old) infants resulted in clinically
relevant defects in T-cell–mediated immune responses
in vivo at 3 years of age. The difference in immunologic re-
sponses in these 2 studies may be due to the difference in
the age of patients at the time of thymectomy.
Infants with congenital heart disease are often prescribed
steroidsor catecholamines, includingepinephrine, to stabilize
hemodynamics during the perioperative period. Steroid hor-
mones, such as methylprednisolone, reduce T-cell number.17
The administration of epinephrine also affects the number of
T cells.18 However, none of the patients in this study were ad-
ministered these medications before or during the operation.
Patients with complete thymectomy experienced a signifi-
cantly higher frequency of hospitalization associated with
common infectious diseases, such as bronchitis. However,
none of them experienced major complications (eg,ery c March 2013
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FIGURE 1. Peripheral blood cell count after thymectomy. A and B, Three-year monitoring of peripheral blood cell count. Indicated cell populations (cell
count per mm3) were measured before and 0.5 to 3 years after surgery. Numbers in top plot indicate the numbers of patients for measurements at individual
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B, Data from subgroups of patients aged less than 20 days at the time of surgery. C and D, Isolated T cells were cultured in the presence or absence of PHA.
Indicated are the values of PHA-induced stimulation index. Dots represent the results from individual patients, and bars indicate the means. Open circles
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Patient identification numbers in (D) refer to the patient numbers indicated in Tables E1 and E2. CPB, Cardiopulmonary bypass; IgG, immunoglobulin G;
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Dmediastinitis or bacteremia) after surgery or required intensive
care for severe immunologic complications during the follow-
up period, as was previously reported.6,7 In contrast, patients
with complete DiGeorge syndrome and chromosome
22q11.2 deletion syndrome and who lack the thymus
congenitally presented with severe and recurrent infectious
diseases.19,20 The less severe immunologic defects in the
completely thymectomized patients than in the congenitally
athymic patients suggest the role of embryonic and neonatal
T-cell development in the thymus before surgery.
A recent report has indicated the restoration of thymic tis-
sues in approximately 10 patients after approximately 30
years have passed since they underwent thymectomy during
infancy, as identified frommagnetic resonance imaging scans
and the detection of na€ıve T cells in the blood, suggesting that
long-term regrowth of thymic tissue may compensate for the
reduction in T-cell number during early childhood.21 Extra-
thymic development of T cells alsowas suggested in childrenCD4þCD25þFoxp3þ regulatory T cells (per mm3) in peripheral blood 3 years a
dicate the means.Open circles indicate patients without CPB, and filled circles in
20 days at the time of surgery (Figure E2). Patient identification numbers
CPB, Cardiopulmonary bypass.
660 The Journal of Thoracic and Cardiovascular Surgwho had undergone thymectomy in infancy.22 Nonetheless,
we noted a reduction in regulatory T-cell number in the com-
pletely thymectomized patients. Mice that were thymectom-
ized 3 days after birth exhibited a reduction in regulatory
T-cell number and a subsequent increase in the frequency
of autoimmune diseases.14,15 Thus, complete thymectomy
may cause further immunologic complications even when
T-cell number is restored later in life.
Because the patients’ well-being was the top priority,
complete thymectomy was carried out only when it was
deemed absolutely necessary, and the thymuses were at
least partially preserved whenever possible. Thus, the com-
pletely thymectomized patients tended to have more severe
CHDs and were younger than the patients who underwent
no or partial thymectomy. In this regard, the reduction in
both T-cell number and T-cell–mediated immune responses
in the completely thymectomized patients could be associ-
ated with age or severity of CHDs. However, body weightfter surgery. Dots represent the results for individual patients, and bars in-
dicate patients with CPB. D, Data from subgroups of patients aged less than
in (D) refer to the patient numbers indicated in Tables E1 and E2.
ery c March 2013
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Dincrease and T-cell development before surgery were not
compromised even in the completely thymectomized pa-
tients. In addition, a comparison between subgroups of pa-
tients whose ages were normalized (Figure E2) indicated
that the subsequent decrease in T-cell number and the defec-
tive T-cell–mediated immune responses were due to com-
plete thymectomy rather than other preexisting conditions
before surgery. Furthermore, these immunologic parame-
ters appeared unaffected in patients with or without CPB
at the time of surgery.Study Limitations
Our study sample sizewas small, and the study design was
not randomizedor age-matched because of the limited enroll-
ment. In regard to disease severity, group C patients tended to
present with a severe disease during the operation, and their
operations were performed at a younger age than group P pa-
tients (Tables E1 and E2). Nonetheless, the comparison
between age-matched subgroups C’ and P’ patients repro-
duced all the results obtained by the comparison between
groups C and P. On the other hand, the difference in surgical
procedures such asCPBdid not seem to affect the subsequent
immunologic parameters (Figures 1-3). Future analysis of
multiple variables, including cyanotic status after the
operation, completeness of the repair, time for CPB and
crossclamp, and temperature, will help further clarify the
contribution of complete thymectomy to the immunologic
parameters, including the onset of infectious diseases.23,24
Another limitation is that blood examination in some pa-
tients could not be continued for 3 years because the parents
haddecided todiscontinueparticipation in thevoluntaryblood
collection in the middle of the study, out of concern that theirThe Journal of Thoracic and Cachildwould experience undue stress posedby such an invasive
method; thus, the number of patients decreased during the
course of the study. Nevertheless, interviews held every 6
months were completed for all the patients.
CONCLUSIONS
On the basis of these findings, we would like to propose
that complete thymectomy should be avoided and at least
a portion of the thymus be preserved during surgery for
CHDs in early infancy to minimize adverse effects on the
immune system. In the case that complete thymectomy can-
not be avoided because of surgical complexity, transplanta-
tion of the removed thymus should be considered to
preserve immune system development in patients.25
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Dr Joren Madsen (Boston, Mass). Excellent presentation and
a well-designed study. What surprises me most about this study
and studies like it is not that there are perturbations in the immune662 The Journal of Thoracic and Cardiovascular Surgsystem after neonatal thymectomy but how minor those perturba-
tions really are, because the thymus is an organ of self-tolerance.
I can think of 2 reasons for this. The first is because the human
immune system and the T-cell repertoire are fairly established at
the time of birth, unlike some other species, such as the mouse,
in which neonatal thymectomy results in a DiGeorge-type syn-
drome. The other reason is that new data suggest that there are
other places than the thymus where T-cell precursors are educated
to distinguish self from nonself.
Compared with other studies that also show a diminution or re-
duction in circulating T cells but no increase in infectious compli-
cations after thymectomy, your study shows an increase in
hospitalizations during the first 3 years of life. What’s different
about your study that you do see an increase in infectious compli-
cations after neonatal thymectomy?
DrKurobe.This difference is related to a broader definition of in-
fectioncomplication thanweused in our study,which includedminor
infections such as bronchitis and pneumonia. In our study, therewere
no patients withmajor complications such as bacteremia ormeningi-
tis, which was in a previous published report. There were no patients
in our study with rubella and major infection during these 3 years.
Dr Madsen. The second question has to do with your in vitro
analysis of the circulating T cells performed using PHAstimulation.
That is a crude way to analyze T-cell function, and I’m wondering
if youdid anymore subtle analysis ofT-cell function by, for instance,
a mixed lymphocyte reaction using irradiated allogeneic cells.
The reason I ask is because some of these children eventually go
on to heart transplantation. If you found that neonatal thymectomy
generates a hole in T-cell repertoire, it might actually help us in tai-
loring or minimizing immunosuppression for those patients who
go on to transplantation.
Dr Kurobe. Also, a PHA stimulation test was done, and there is
no significant difference between groups P and E. So I think there is
nodifference in theT-cell function betweenboth groups. I havenever
done an analysis of T-cell function except a PHA stimulation test.
Dr Madsen. Third question: Let’s assume that you’re right and
neonatal thymectomy does have significant immunologic sequelae
so thatwe need to avoid neonatal thymectomy. But there are some op-
erations that cannot be performed safely without removing the whole
thymus for exposure.Given this scenario, I see2 options.One is to dis-
cern and then treat the immune dysfunction caused by thymectomy.
For instance, giving these patients supplemental measles or rubella
booster vaccines to raise their antibody titers. My question is about
the potential second option: Is there a surgicalway tomaintain thymic
function at the same time you perform a neonatal thymectomy?
Dr Kurobe. I think this question is important and difficult to an-
swer. As you know, there are some published reports about the trans-
plantation in patients with DiGeorge syndrome, and there is also
a study in which autologous thymic tissuewas implanted into the do-
nor heart pig model, thereby creating a composite thymus heart allo-
graft transplant. So this thymus implant was performed in the animal,
and the study reported success for the reconstitution of thymic func-
tion after this transplantation. In the case that complete thymectomy
cannot be avoided, the autotransplantation of the removed thymus
mayoffer a viable option for disturbed immune function after surgery.
However, at this time I believe more investigation will be needed to
clarify the relationship of the thymic autotransplantation because
there is no evidence about thymic transplantation in normal children.ery c March 2013
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FIGURE E1. Representative results for CD3þCD19 T cells and
CD3CD19þ B cells in the peripheral blood of individual patients (cell
number per mm3). Patient numbers in this figure correspond to the patient
numbers indicated in Tables E1 and E2.
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TABLE E2. Patients without thymectomy (patients 18-23) and
patients with partial thymectomy (patients 24-32) (group P)
Patient
no.
Age at
surgery
(d)
BW at
surgery
(kg) Diagnosis Operation
18 60 3.8 VSD Complete repair
19 13 2.5 VSD, PDA PAB, PDA ligation
20 40 3.6 PDA PDA ligation
21 18 2.7 PDA PDA ligation
22 55 3.3 c-TGA BT shunt, PA repair
23 13 4.3 TGA Complete repair
24 84 3.1 VSD, ASD Complete repair
25 77 4.1 TAPVR Complete repair
26 5 3.5 VSD, ASD, PH Complete repair
27 10 2.8 TAPVR Complete repair
28 42 3.0 TAPVR Complete repair
29 77 4.4 SV, PS ASD creation,
PA repair, BT shunt
30 36 3.6 TOF, PA Right BT shunt
31 90 3.7 TOF BT shunt, PA repair
32 19 3.5 Truncus
arteriosus
Complete repair
Average 33.17 3.37
SD 21.39 0.68
Range 5-90 2.5-4.4
BW,Bodyweight; SD, standard deviation; VSD, ventricular septal defect; PDA, patent
ductus arteriosus; c-TGA, corrected transposition of the great arteries; TGA, transpo-
sition of the great arteries; ASD, atrial septal defect; TAPVR, total anomalous pulmo-
nary venous return; PH, pulmonary hypertension; SV, single ventricle; PS, pulmonary
stenosis; TOF, tetralogy of Fallot; PA, pulmonary atresia; PAB, pulmonary artery
banding; BT, Blalock–Tausig.
TABLE E1. Patients who underwent complete thymectomy (group C)
Patient
no.
Age at
surgery
(d)
BW at
surgery
(kg) Diagnosis Operation
1 3 3.2 Truncus
arteriosus,
Complete repair
IAA (type B)
2 27 3.2 TGA Complete repair
3 28 3.3 TGA Complete repair
4 5 3.3 HLHS Norwood operation
5 72 4.4 TAPVR Complete repair
6 8 2.7 TGA Complete repair
7 14 3.4 c-TGA, PA Right modified
BT shunt þ PDA
division
8 10 3.0 TGA Complete repair
9 15 3.6 DORV, CoA Arterial switch,
CoA repair, PAB
10 10 3.4 IAA (A) ASO, arch repair, PAB
11 5 3.2 TGA Complete repair
12 11 3.3 TGA Complete repair
13 8 3.1 VSD, CoA Complete repair
14 3 2.8 HLHS Norwood operation
15 13 3.1 IAA (A), VSD Complete repair
16 14 2.5 Truncus
arteriosus
Complete repair
17 7 2.7 HLHS Norwood operation
Average 14.88 3.19
SD 16.77 0.42
Range 3-72 2.5-4.4
BW, Body weight; SD, standard deviation; IAA, interruption of aortic arch;
TGA, transposition of the great arteries; HLHS, hypoplastic left heart syndrome;
TAPVR, total anomalous pulmonary venous return; c-TGA, corrected transposition
of the great arteries; PA, pulmonary atresia; DORV, double outlet right ventricle;
CoA, coarctation of the aorta; VSD, ventricular septal defect; BT, Blalock–Tausig;
PDA, patent ductus arteriosus; PAB, pulmonary artery banding; ASO, arterial switch
operation.
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